ATARA BIOTHERAPEUTICS, INC. (ATRA) Return on equity 2022–2023
ATARA BIOTHERAPEUTICS, INC. (ATRA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-278.3%FY2023 · since FY2022: -180.3% → -278.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -278.3% | -98.0 pp |
| FY2022 | -180.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRA financial trends
ATRA RevenueATRA Net incomeATRA Net marginATRA Gross profitATRA Gross marginATRA Operating incomeATRA Operating marginATRA Operating cash flowATRA Free cash flowATRA Capital expendituresATRA Stock buybacksATRA Dividends paidATRA Total assetsATRA Total liabilitiesATRA Shareholders’ equityATRA overview →